Storia in 2 fonti

Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.

Raccontata da

cnbc.com

scientificamerican.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo3 mesi fa

Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.

originale

scientificamerican.com3 mesi fa

Trump's psychedelics executive order could accelerate new treatments—including for children

Trump accelerates psychedelic research; FDA evaluates psilocybin for depression, trials on minors inevitable. Regulatory opening creates biotech opportunity but poses ethical risks (developing brain, informed consent): governance and reputational hazards critical.

Leggi questa versione →

Timeline cronologica

domenica 31 maggio 2026·cnbc.com
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
lunedì 1 giugno 2026·scientificamerican.com
Trump's psychedelics executive order could accelerate new treatments—including for children
The Trump administration has fast-tracked research into psychedelics, and experts say it is likely a matter of time before the drugs are used to treat minors